报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 4.15% | -23.71% | 76.6% | 21/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
2024-06-30 | 2.35% | -46.22% | 85.04% | 24/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
2024-03-31 | 1.27% | -28.25% | -78.47% | 21/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
2023-12-31 | 5.9% | -55.84% | 8.46% | 22/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
2023-09-30 | 5.44% | -62.82% | 24.49% | 25/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
2023-06-30 | 4.37% | 46.64% | 146.89% | 18/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
2023-03-31 | 1.77% | 2% | -86.75% | 24/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
2022-12-31 | 13.36% | -20.1% | -8.68% | 16/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
2022-09-30 | 14.63% | 13.68% | 390.94% | 16/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
2022-06-30 | 2.98% | 2% | -82.18% | 28/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
2021-12-31 | 16.72% | -43.17% | 29.91% | 15/51 | -6.68% | 澳洋健康 | 51.68% | 行业排名> |
2021-09-30 | 12.87% | 2% | -56.25% | 14/51 | 2.3% | 澳洋健康 | 40.93% | 行业排名> |
2020-12-31 | 29.42% | -57.03% | -57.03% | 5/51 | 10.95% | 金域医学 | 43.58% | 行业排名> |
2019-12-31 | 68.47% | 104.75% | 104.75% | 3/51 | 65.31% | 金域医学 | 35.41% | 行业排名> |
2018-12-31 | 33.44% | 2% | 2% | 5/51 | -0.6% | 阳光诺和 | 26.2% | 行业排名> |